Stock price is too small for R/S. For these to be successful on a growing company like CBAY, minimum price is $.50 before a split. JCOM was a 1/4 R/S success story I was involved with a few years back. R/S from $.50 to $2.00 then ran to $70 in about 1 year with about 30 mil shares o/s after the split. For a R/S to be successful, all shares including the convertable preferred must be part of the split. IMO, a R/S may not be necessary if the company takes certain actions like the following.
IMO, CBAY needs to get rid of the Convertable A in total and attach a dividend to the common in the form of a preferred stock activation for hostile takeover candidates to buy. This takes care of the poison pill. I think the market would like that better than having a stash of 50/1 converable preferreds in a back room whether or not they would only be used for poison pill purposes.